Published in Eur J Health Econ on March 01, 2007
Predictive risk modelling in the Spanish population: a cross-sectional study. BMC Health Serv Res (2013) 0.90
Improving the prediction model used in risk equalization: cost and diagnostic information from multiple prior years. Eur J Health Econ (2014) 0.81
A Review on Methods of Risk Adjustment and their Use in Integrated Healthcare Systems. Int J Integr Care (2016) 0.75
Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization. Eur J Health Econ (2015) 0.75
Evaluating diagnosis-based case-mix measures: how well do they apply to the VA population? Med Care (2001) 1.33
Needs for further improvement: risk adjustment in the German health insurance system. Health Policy (2003) 0.80
Performance of diagnosis-based risk adjustment measures in a population of sick Australians. Aust N Z J Public Health (2002) 0.76
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71
Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int (2009) 2.72
The cost-effectiveness of duloxetine in chronic low back pain: a US private payer perspective. Value Health (2013) 2.10
Introducing the German Mouse Clinic: open access platform for standardized phenotyping. Nat Methods (2005) 1.93
Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ Res (2005) 1.86
Prolonged recruitment efforts in health surveys: effects on response, costs, and potential bias. Epidemiology (2006) 1.64
A claims data-based comparison of comorbidity in individuals with and without dementia. BMC Geriatr (2014) 1.58
Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc (2002) 1.54
Risk adjustment and risk selection on the sickness fund insurance market in five European countries. Health Policy (2003) 1.37
Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective. Appl Health Econ Health Policy (2013) 1.32
Analysis of SF-6D index data: is beta regression appropriate? Value Health (2011) 1.30
Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000. Arch Intern Med (2005) 1.28
Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum Genet (2003) 1.24
Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol (2007) 1.22
High-resolution SNP scan of chromosome 6p21 in pooled samples from patients with complex diseases. Genomics (2003) 1.22
Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol (2010) 1.21
Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices. Ger Med Sci (2006) 1.20
Multimorbidity and health-related quality of life in the older population: results from the German KORA-age study. Health Qual Life Outcomes (2011) 1.18
Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data. BMC Health Serv Res (2012) 1.16
Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population. Eur Heart J (2008) 1.16
Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care (2006) 1.15
Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage. Value Health (2011) 1.15
Dyslipidemia in primary care--prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol (2008) 1.14
Medical care of type 2 diabetes in German disease management programmes: a population-based evaluation. Diabetes Metab Res Rev (2011) 1.13
Prevalence of obesity in primary care using different anthropometric measures--results of the German Metabolic and Cardiovascular Risk Project (GEMCAS). BMC Public Health (2008) 1.13
Treatment costs and indirect costs of cluster headache: A health economics analysis. Cephalalgia (2011) 1.11
[Extent of rationing and overprovision in stationary care: results of a nationwide survey of German hospitals]. Dtsch Med Wochenschr (2015) 1.11
Health-related quality of life in patients with severe COPD hospitalized for exacerbations - comparing EQ-5D, SF-12 and SGRQ. Health Qual Life Outcomes (2010) 1.10
Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study. Cardiovasc Diabetol (2010) 1.09
Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab (2008) 1.08
Tooth loss after active periodontal therapy. 1: patient-related factors for risk, prognosis, and quality of outcome. J Clin Periodontol (2008) 1.08
Costs associated with treatment of chronic low back pain: an analysis of the UK General Practice Research Database. Spine (Phila Pa 1976) (2013) 1.07
Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: a health technology assessment report. Int J Technol Assess Health Care (2010) 1.06
Regional differences in the prevalence of the metabolic syndrome in primary care practices in Germany. Dtsch Arztebl Int (2008) 1.06
Observational study mortality in treated primary aldosteronism: the German Conn's registry. Hypertension (2012) 1.04
Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study. Ann Med (2010) 1.04
A value set for the EQ-5D based on experienced health states: development and testing for the German population. Pharmacoeconomics (2011) 1.04
Elasticities of market shares and social health insurance choice in Germany: a dynamic panel data approach. Health Econ (2007) 1.04
Diabetic retinopathy and health-related quality of life. Graefes Arch Clin Exp Ophthalmol (2008) 1.03
Risk adjustment and risk selection in Europe: 6 years later. Health Policy (2007) 1.03
A valid instrument for measuring informal care time for people with dementia. Int J Geriatr Psychiatry (2009) 1.02
Cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA Survey 2000. Diabetes Care (2004) 1.01
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood (2004) 1.01
Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. Diabetes Care (2006) 1.01
Official statistics and claims data records indicate non-response and recall bias within survey-based estimates of health care utilization in the older population. BMC Health Serv Res (2013) 1.01
Overweight, obesity and high waist circumference: regional differences in prevalence in primary medical care. Dtsch Arztebl Int (2008) 1.00
Preconditions for efficiency and affordability in competitive healthcare markets: are they fulfilled in Belgium, Germany, Israel, the Netherlands and Switzerland? Health Policy (2013) 1.00
Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany. Inflamm Bowel Dis (2010) 0.99
Radiographic parameters as prognostic indicators for healing of class II furcation defects. J Clin Periodontol (2004) 0.99
Financial incentives for disease management programmes and integrated care in German social health insurance. Health Policy (2005) 0.99
The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes (2003) 0.99
Measurement of informal care time in a study of patients with dementia. Int Psychogeriatr (2008) 0.99
Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol (2010) 0.98
The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings. J Alzheimers Dis (2013) 0.98
Is inflammation a causal chain between low socioeconomic status and type 2 diabetes? Results from the KORA Survey 2000. Eur J Epidemiol (2006) 0.98
Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care (2009) 0.97
Socioeconomic status is not associated with type 2 diabetes incidence in an elderly population in Germany: KORA S4/F4 cohort study. J Epidemiol Community Health (2010) 0.96
The molecular genetic architecture of self-employment. PLoS One (2013) 0.96
Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies. Cardiovasc Diabetol (2012) 0.96
Direct medical costs of COPD--an excess cost approach based on two population-based studies. Respir Med (2011) 0.95
Long-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. III. Class II furcations after 10 years. J Periodontol (2006) 0.95
Relationship between posttraumatic stress disorder and type 2 diabetes in a population-based cross-sectional study with 2970 participants. J Psychosom Res (2013) 0.94
Body weight changes and outpatient medical care utilisation: Results of the MONICA/KORA cohorts S3/F3 and S4/F4. Psychosoc Med (2012) 0.94
[Differences between Eastern European immigrants of German origin and the rest of the German population in health status, health care use and health behaviour: a comparative study using data from the KORA-Survey 2000]. Soz Praventivmed (2005) 0.93
Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs. Int J Cardiol (2012) 0.93
Uncertainty assessment of input parameters for economic evaluation: Gauss's error propagation, an alternative to established methods. Med Decis Making (2009) 0.93
Effects of the German reference drug program on ex-factory prices of prescription drugs: a panel data approach. Health Econ (2009) 0.93
Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data. BMC Health Serv Res (2013) 0.92
Albuminuria, cardiovascular risk factors and disease management in subjects with type 2 diabetes: a cross sectional study. BMC Health Serv Res (2008) 0.92
Nurse-based case management for aged patients with myocardial infarction: study protocol of a randomized controlled trial. BMC Geriatr (2010) 0.91
Salivary cortisol in a middle-aged community sample: results from 990 men and women of the KORA-F3 Augsburg study. Eur J Endocrinol (2010) 0.91
Social inequalities and outcomes in type 2 diabetes in the German region of Augsburg. A cross-sectional survey. Int J Public Health (2007) 0.91
Impact of educational level on health-related quality of life (HRQL): results from Germany based on the EuroQol 5D (EQ-5D). Eur J Public Health (2012) 0.91
Langendorff heart: a model system to study cardiovascular effects of engineered nanoparticles. ACS Nano (2011) 0.91
The KORA Eye Study: a population-based study on eye diseases in Southern Germany (KORA F4). Invest Ophthalmol Vis Sci (2011) 0.91
Hypoadiponectinemia and proinflammatory state: two sides of the same coin?: results from the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4). Diabetes Care (2006) 0.91
Non-surgical periodontal therapy with adjunctive topical doxycycline: a double-blind randomized controlled multicenter study. J Clin Periodontol (2002) 0.91
Longitudinal beta regression models for analyzing health-related quality of life scores over time. BMC Med Res Methodol (2012) 0.91
Comparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis. BMC Public Health (2005) 0.90
Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany. GMS Health Technol Assess (2010) 0.90
Nonsurgical and surgical periodontal therapy in single-rooted teeth. Clin Oral Investig (2007) 0.90
Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Eur J Endocrinol (2006) 0.89
Socioeconomic position, resilience, and health behaviour among elderly people. Int J Public Health (2011) 0.89
Clinical effectiveness and cost effectiveness of tailoring chronic hepatitis C treatment with peginterferon alpha-2b plus ribavirin to HCV genotype and early viral response: a decision analysis based on German guidelines. Pharmacoeconomics (2009) 0.89
Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines. Clin Res Cardiol (2013) 0.89
A network against failing hearts--introducing the German "Competence Network Heart Failure". Int J Cardiol (2009) 0.88
The correlation between waist circumference and ESC cardiovascular risk score: data from the German metabolic and cardiovascular risk project (GEMCAS). Clin Res Cardiol (2008) 0.88
Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care, short: Youth with Extreme Obesity Study (YES). BMC Public Health (2013) 0.88
Principle and mechanism of direct porphyrin metalation: joint experimental and theoretical investigation. J Am Chem Soc (2007) 0.88
Stability of clinical and radiographic results after guided tissue regeneration in infrabony defects. J Periodontol (2007) 0.88
Effects of general practitioner training and family support services on the care of home-dwelling dementia patients--results of a controlled cluster-randomized study. BMC Health Serv Res (2010) 0.88
Cost of illness in patients with Gilles de la Tourette's syndrome. J Neurol (2010) 0.88
Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study. Eur J Health Econ (2012) 0.87
Disease management programmes for patients with coronary heart disease--an empirical study of German programmes. Health Policy (2008) 0.87
A randomised, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation. Arzneimittelforschung (2002) 0.87
The influence of transformational leadership on employee well-being: results from a survey of companies in the information and communication technology sector in Germany. J Occup Environ Med (2013) 0.87